Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura.

Zaja, Francesco

Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura. [electronic resource] - Haematologica Jun 2008 - 930-3 p. digital

Publication Type: Journal Article

1592-8721

10.3324/haematol.12206 doi


Adolescent
Adult
Aged
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
B-Lymphocytes--metabolism
Disease-Free Survival
Female
Humans
Immunologic Factors--administration & dosage
Male
Middle Aged
Platelet Count
Purpura, Thrombocytopenic, Idiopathic--drug therapy
Rituximab
Time Factors
Treatment Outcome